ENTPD1 and HIV infectious disease: CD39+ Tregs suppress IL-2 production in CD4+ T cells through the CD39/A2AR/cAMP pathway, and a high frequency of CD39+ Tregs correlates with poor clinical outcomes in HIV infection [221].